AMGEN BIOFARMACEUTICA, LDA secures contract for 1833/2025- Acquisition Of A53284- Adalimumab [20 Mg; Syringe] (Patients Undergoing Treatment)

Portugal, Nov. 12 -- Portugal based AMGEN BIOFARMACEUTICA, LDA has secured contract from Unidade Local De Saude De Lisboa Ocidental, E. P. E. for 1833/2025- Acquisition Of A53284- Adalimumab [20 Mg; Syringe] (Patients Undergoing Treatment). The value of the contract is worth 56250 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....